Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-07

Clinical Trial Update: Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from the University of Oslo School of Pharmacy evaluating strategies to lower total immunosuppressive load in renal transplant recipien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oslo School of Pharmacy | Conditions: Renal Transplantation | Phase 4 | Status: TERMINATED